Skip to main content
Premium Trial:

Request an Annual Quote

Genomics From the Inside

Premium

Gary Zweiger has no illusions of being the next Jack Welch, but neither does he have doubts that his new book will fill a critical gap in genomics education.

“I felt that there are some tremendously profound changes occurring in the biomedical sciences with implications for health — and even beyond that, to our conception of who we are,” he says. “The focus [of the book] is on the transformation of biology from molecular studies to an information science, and on the interplay between government efforts and industry efforts.”

Zweiger’s Transducing the Genome: Information, Anarchy, and Revolution in the Biomedical Sciences (released this month) aims to educate people about the ever-changing field of genomics. Though the book is written for anyone to understand, he says, “the people that will most appreciate this are working scientists who want to know more about genomics and the history of it.” The book tackles genomics from several angles, including its history, technologies, major players, and outlook.

Zweiger, currently director of business development and strategic planning for Agilent Technologies, may be in a unique position to accomplish this goal. He has a doctorate in genetics and worked as a scientist at Genentech and Incyte; but he has also been a consultant for genomics startups and a strategic advisor, first at Incyte and now at Agilent. Flip-flopping between science and business has given Zweiger a unique perspective on the field.

“The other accounts out there are from journalists or from people that are squarely in the government-supported field of work, and their accounts of what is going on in the industry are lacking,” he contends.

At 36, Zweiger says that he’s still trying to decide what to do with his life. Though he’s bounced around a bit, he says that his only business background is what he’s picked up on the job. “I’ve had fun with it, is the important thing,” he says. As for the book, it probably won’t change his life. “I don’t expect to make a lot of money,” he laughs.

—Meredith Salisbury

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.